BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Scagnolari C, Corano Scheri G, Selvaggi C, Schietroma I, Najafi Fard S, Mastrangelo A, Giustini N, Serafino S, Pinacchio C, Pavone P, Fanello G, Ceccarelli G, Vullo V, d'Ettorre G. Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study. Int J Mol Sci 2016;17:E1639. [PMID: 27689995 DOI: 10.3390/ijms17101639] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
2 Ringel Y, Maharshak N, Ringel-Kulka T, Wolber EA, Sartor RB, Carroll IM. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes. 2015;6:173-181. [PMID: 25915459 DOI: 10.1080/19490976.2015.1044711] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 15.0] [Reference Citation Analysis]
3 Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin. 2017;33:1191-1197. [PMID: 28166427 DOI: 10.1080/03007995.2017.1292230] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 8.8] [Reference Citation Analysis]
4 Taverniti V, Guglielmetti S. Methodological issues in the study of intestinal microbiota in irritable bowel syndrome. World J Gastroenterol. 2014;20:8821-8836. [PMID: 25083056 DOI: 10.3748/wjg.v20.i27.8821] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
5 Raschi E, De Ponti F. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome. Expert Opin Drug Metab Toxicol. 2014;10:293-305. [PMID: 24387275 DOI: 10.1517/17425255.2013.876410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
6 DuPont HL. Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases. Mayo Clin Proc. 2015;90:1116-1124. [PMID: 26162610 DOI: 10.1016/j.mayocp.2015.04.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
7 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm] [Cited by in Crossref: 21] [Article Influence: 4.2] [Reference Citation Analysis]
8 Sawin EA, De Wolfe TJ, Aktas B, Stroup BM, Murali SG, Steele JL, Ney DM. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol Gastrointest Liver Physiol 2015;309:G590-601. [PMID: 26251473 DOI: 10.1152/ajpgi.00211.2015] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 12.2] [Reference Citation Analysis]
9 Wang X, Qi Q, Wang Y, Wu H, Jin X, Yao H, Jin D, Liu Y, Wang C. Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome. Chin Med. 2018;13:63. [PMID: 30574173 DOI: 10.1186/s13020-018-0220-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
10 Katzenberger RJ, Ganetzky B, Wassarman DA. The gut reaction to traumatic brain injury. Fly (Austin) 2015;9:68-74. [PMID: 26291482 DOI: 10.1080/19336934.2015.1085623] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
11 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm.s93698] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
12 Son JS, Zheng LJ, Rowehl LM, Tian X, Zhang Y, Zhu W, Litcher-Kelly L, Gadow KD, Gathungu G, Robertson CE, Ir D, Frank DN, Li E. Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection. PLoS One 2015;10:e0137725. [PMID: 26427004 DOI: 10.1371/journal.pone.0137725] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 18.0] [Reference Citation Analysis]
13 Hungin AP, Becher A, Cayley B, Heidelbaugh JJ, Muris JW, Rubin G, Seifert B, Russell A, De Wit NJ. Irritable bowel syndrome: an integrated explanatory model for clinical practice. Neurogastroenterol Motil 2015;27:750-63. [PMID: 25703486 DOI: 10.1111/nmo.12524] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis 2016;1:135-45. [PMID: 29922669 DOI: 10.1159/000447252] [Cited by in Crossref: 110] [Cited by in F6Publishing: 90] [Article Influence: 22.0] [Reference Citation Analysis]
15 Engevik MA, Banks LD, Engevik KA, Chang-Graham AL, Perry JL, Hutchinson DS, Ajami NJ, Petrosino JF, Hyser JM. Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence. Gut Microbes 2020;11:1324-47. [PMID: 32404017 DOI: 10.1080/19490976.2020.1754714] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
16 Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Neurogastroenterol Motil. 2015;27:705-716. [PMID: 25809913 DOI: 10.1111/nmo.12544] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
17 Yu SW, Rao SS. Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide. Therap Adv Gastroenterol. 2014;7:193-205. [PMID: 25177366 DOI: 10.1177/1756283x14537882] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
18 Boem F, Ferretti G, Zipoli Caiani S. Out of our skull, in our skin: the Microbiota-Gut-Brain axis and the Extended Cognition Thesis. Biol Philos 2021;36. [DOI: 10.1007/s10539-021-09790-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ringel Y. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders. Gastroenterology Clinics of North America 2017;46:91-101. [DOI: 10.1016/j.gtc.2016.09.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
20 Cohen NA, Maharshak N. Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci. 2017;62:1131-1145. [PMID: 28315032 DOI: 10.1007/s10620-017-4535-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
21 Borody T, Fischer M, Mitchell S, Campbell J. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead. Expert Rev Gastroenterol Hepatol. 2015;9:1379-1391. [PMID: 26414076 DOI: 10.1586/17474124.2015.1086267] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
22 Schäffler H, Breitrück A. Clostridium difficile - From Colonization to Infection. Front Microbiol 2018;9:646. [PMID: 29692762 DOI: 10.3389/fmicb.2018.00646] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 18.3] [Reference Citation Analysis]
23 Ringel-Kulka T, Goldsmith JR, Carroll IM, Barros SP, Palsson O, Jobin C, Ringel Y. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther. 2014;40:200-207. [PMID: 24853043 DOI: 10.1111/apt.12800] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
24 Ringel-Kulka T, Choi CH, Temas D, Kim A, Maier DM, Scott K, Galanko JA, Ringel Y. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol. 2015;110:1339-1346. [PMID: 26303129 DOI: 10.1038/ajg.2015.220] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 10.5] [Reference Citation Analysis]
25 Komuro H, Sato N, Sasaki A, Suzuki N, Kano M, Tanaka Y, Yamaguchi-Kabata Y, Kanazawa M, Warita H, Aoki M, Fukudo S. Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome. PLoS One 2016;11:e0147817. [PMID: 26808377 DOI: 10.1371/journal.pone.0147817] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
26 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126-14131. [PMID: 25339801 DOI: 10.3748/wjg.v20.i39.14126] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 77] [Article Influence: 15.8] [Reference Citation Analysis]
27 Ivashkin V, Poluektov Y, Kogan E, Shifrin O, Sheptulin A, Kovaleva A, Kurbatova A, Krasnov G, Poluektova E. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome. PLoS One 2021;16:e0252930. [PMID: 34115808 DOI: 10.1371/journal.pone.0252930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li L, Cui H, Li T, Qi J, Chen H, Gao F, Tian X, Mu Y, He R, Lv S, Chu F, Xu B, Wang P, Lei H, Xu H, Wang C. Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo. Front Pharmacol 2020;11:1210. [PMID: 32982718 DOI: 10.3389/fphar.2020.01210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Skrypnik K, Suliburska J. Association between the gut microbiota and mineral metabolism. J Sci Food Agric 2018;98:2449-60. [PMID: 28991359 DOI: 10.1002/jsfa.8724] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 17.0] [Reference Citation Analysis]
30 Ringel-kulka T, Mcrorie J, Ringel Y. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating. American Journal of Gastroenterology 2017;112:145-51. [DOI: 10.1038/ajg.2016.511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Cheng YW, Fischer M. The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Curr Treat Options Gastroenterol 2017;15:349-62. [PMID: 28748314 DOI: 10.1007/s11938-017-0143-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146:1500-1512. [PMID: 24583088 DOI: 10.1053/j.gastro.2014.02.037] [Cited by in Crossref: 234] [Cited by in F6Publishing: 174] [Article Influence: 33.4] [Reference Citation Analysis]
33 Ludidi S, Jonkers D, Elamin E, Pieters HJ, Schaepkens E, Bours P, Kruimel J, Conchillo J, Masclee A. The intestinal barrier in irritable bowel syndrome: subtype-specific effects of the systemic compartment in an in vitro model. PLoS One 2015;10:e0123498. [PMID: 25978614 DOI: 10.1371/journal.pone.0123498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
34 Gualtieri P, Marchetti M, Cioccoloni G, De Lorenzo A, Romano L, Cammarano A, Colica C, Condò R, Di Renzo L. Psychobiotics Regulate the Anxiety Symptoms in Carriers of Allele A of IL-1β Gene: A Randomized, Placebo-Controlled Clinical Trial. Mediators Inflamm 2020;2020:2346126. [PMID: 32377159 DOI: 10.1155/2020/2346126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Xiao Y, Liu Y, Huang S, Sun X, Tang Y, Cheng J, Wang T, Li F, Kuang Y, Luo R. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials. PLoS One. 2015;10:e0122397. [PMID: 25853241 DOI: 10.1371/journal.pone.0122397] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
36 Llanos-Chea A, Fasano A. Gluten and Functional Abdominal Pain Disorders in Children. Nutrients 2018;10:E1491. [PMID: 30322070 DOI: 10.3390/nu10101491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
37 Mazzawi T, Lied GA, Sangnes DA, El-Salhy M, Hov JR, Gilja OH, Hatlebakk JG, Hausken T. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLoS One 2018;13:e0194904. [PMID: 30427836 DOI: 10.1371/journal.pone.0194904] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
38 Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015;125:926-938. [PMID: 25689247 DOI: 10.1172/jci76304] [Cited by in Crossref: 615] [Cited by in F6Publishing: 302] [Article Influence: 102.5] [Reference Citation Analysis]
39 Mosińska P, Szczepaniak A, Fichna J. Bile acids and FXR in functional gastrointestinal disorders. Digestive and Liver Disease 2018;50:795-803. [DOI: 10.1016/j.dld.2018.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Li Q, Guo CH, Chowdhury MA, Dai TL, Han W. TRPA1 in the spinal dorsal horn is involved in post-inflammatory visceral hypersensitivity: in vivo study using TNBS-treated rat model. J Pain Res 2016;9:1153-60. [PMID: 27980434 DOI: 10.2147/JPR.S118581] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
41 Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol. 2016;50:227-232. [PMID: 25930973 DOI: 10.1097/mcg.0000000000000327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
42 Gareau MG. Microbiota-gut-brain axis and cognitive function. Adv Exp Med Biol 2014;817:357-71. [PMID: 24997042 DOI: 10.1007/978-1-4939-0897-4_16] [Cited by in Crossref: 85] [Cited by in F6Publishing: 62] [Article Influence: 12.1] [Reference Citation Analysis]
43 Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol. 2014;20:15163-15176. [PMID: 25386066 DOI: 10.3748/wjg.v20.i41.15163] [Cited by in CrossRef: 229] [Cited by in F6Publishing: 180] [Article Influence: 38.2] [Reference Citation Analysis]
44 Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep 2019;9:12210. [PMID: 31434935 DOI: 10.1038/s41598-019-48554-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
45 Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol. 2015;21:3072-3084. [PMID: 25780308 DOI: 10.3748/wjg.v21.i10.3072] [Cited by in CrossRef: 157] [Cited by in F6Publishing: 113] [Article Influence: 26.2] [Reference Citation Analysis]
46 Joo YE. Alteration of fecal microbiota in patients with postinfectious irritable bowel syndrome. J Neurogastroenterol Motil. 2015;21:135-137. [PMID: 25611066 DOI: 10.5056/jnm14133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
47 Shui L, Yang X, Li J, Yi C, Sun Q, Zhu H. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.Front Immunol. 2019;10:2989. [PMID: 32010123 DOI: 10.3389/fimmu.2019.02989] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 27.0] [Reference Citation Analysis]
48 Mei L, Zhou J, Su Y, Mao K, Wu J, Zhu C, He L, Cui Y. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol 2021;21:105. [PMID: 33663411 DOI: 10.1186/s12876-021-01693-w] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis. 2016;1:135-145. [PMID: 29922669 DOI: 10.1159/000447252.] [Reference Citation Analysis]
50 Gudsoorkar VS, Quigley EM. Colorectal sensation and motility. Curr Opin Gastroenterol. 2014;30:75-83. [PMID: 24257038 DOI: 10.1097/mog.0000000000000028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
51 Chen C, Chen Y, Liou J, Wu M; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. From germ theory to germ therapy. Kaohsiung J Med Sci 2019;35:73-82. [DOI: 10.1002/kjm2.12011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Du EJ, Ahn TJ, Kwon I, Lee JH, Park JH, Park SH, Kang TM, Cho H, Kim TJ, Kim HW, Jun Y, Lee HJ, Lee YS, Kwon JY, Kang K. TrpA1 Regulates Defecation of Food-Borne Pathogens under the Control of the Duox Pathway. PLoS Genet 2016;12:e1005773. [PMID: 26726767 DOI: 10.1371/journal.pgen.1005773] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
53 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 30.0] [Reference Citation Analysis]
54 De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol 2014;592:2989-97. [PMID: 24756641 DOI: 10.1113/jphysiol.2014.273995] [Cited by in Crossref: 159] [Cited by in F6Publishing: 137] [Article Influence: 22.7] [Reference Citation Analysis]
55 Ringel Y, Ringel-Kulka T. The Intestinal Microbiota and Irritable Bowel Syndrome. J Clin Gastroenterol. 2015;49 Suppl 1:S56-S59. [PMID: 26447966 DOI: 10.1097/mcg.0000000000000418] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
56 Hod K, Sperber AD, Maharshak N, Ron Y, Shapira I, David Z, Rogowski O, Berliner S, Shenhar-Tsarfaty S, Dekel R. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls. Neurogastroenterol Motil 2018;30:e13464. [PMID: 30240124 DOI: 10.1111/nmo.13464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
57 Stern EK, Brenner DM. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2018;9:e134. [PMID: 29446765 DOI: 10.1038/ctg.2018.2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
58 He X, Cui LH, Wang XH, Yan ZH, Li C, Gong SD, Zheng Y, Luo Z, Wang Y. Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome. Oncotarget 2017;8:113957-65. [PMID: 29371960 DOI: 10.18632/oncotarget.23045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
59 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 15.6] [Reference Citation Analysis]
60 Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol. 2016;9:199-212. [PMID: 26929782 DOI: 10.1177/1756283x15621230] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 8.4] [Reference Citation Analysis]
61 Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect 2018;76:111-20. [PMID: 29291933 DOI: 10.1016/j.jinf.2017.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
62 Kondo T, Miwa H. The Role of Esophageal Hypersensitivity in Functional Heartburn. Journal of Clinical Gastroenterology 2017;51:571-8. [DOI: 10.1097/mcg.0000000000000885] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]